symbol,statement_type,period_end,line_item,value
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,66398630.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,66398630.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,92390000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,1543330000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,2399500000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,1352900000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,1543330000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,92390000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,2399500000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,2399500000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,2399500000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,2399500000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,2266700000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Fixed Assets Revaluation Reserve,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,132800000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,132800000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,383100000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,124060000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,30700000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,76320000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,76320000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,6660000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,259040000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,32000000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Deferred Taxes Liabilities,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,16070000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,16070000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,10140000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Payables,97340000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,97340000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,2782600000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,1170660000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,44230000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Defined Pension Benefit,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,173910000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Held To Maturity Securities,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,173910000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Trading Securities,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,856170000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,759240000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Goodwill,96930000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,88370000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,88370000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,88370000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Properties,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,1611940000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,40190000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Hedging Assets Current,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Assets Held For Sale Current,0.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Deferred Assets,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Inventory,152000000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,131760000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,1287990000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,1175840000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,112150000.0
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
JAGSNPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,66094485.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,66094485.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,89410000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,1874020000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,1874020000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,1801260000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,1874020000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,89410000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,1874020000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,1874020000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,1874020000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,1874020000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,170700000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Fixed Assets Revaluation Reserve,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,1041910000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,111200000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,132190000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,132190000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,296760000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,105480000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,9180000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,20730000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,75570000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,75570000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,9180000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,191280000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,1050000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Deferred Taxes Liabilities,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,13840000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,13840000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,7520000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,7520000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Payables,150930000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,74190000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,780000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,0.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,75960000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,2170780000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,178240000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,21060000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Defined Pension Benefit,21060000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,4700000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,47000000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Held To Maturity Securities,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,47000000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Trading Securities,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Goodwill,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,93020000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-11280000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,104300000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,83920000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,20380000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,0.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,0.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,1992540000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,80830000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Hedging Assets Current,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Assets Held For Sale Current,171790000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Deferred Assets,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,81930000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Inventory,149970000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,77090000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,12640000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,60240000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,109510000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-10530000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,120040000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,1479340000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,1351740000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,127600000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,70100000.0
JAGSNPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,57500000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,65495000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,65495000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,60010000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,1588900000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,1588900000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,1369880000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,1588900000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,60010000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,1588900000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,1588900000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,1588900000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,1588900000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,87650000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Fixed Assets Revaluation Reserve,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,945370000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,6000000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,130990000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,130990000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,360560000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,84850000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,10750000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,21630000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,52470000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,52470000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,10750000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,275710000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,1400000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Deferred Taxes Liabilities,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,7540000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,7540000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,0.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,3760000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,3755000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Payables,251090000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,85100000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,0.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,190000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,165800000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,1949460000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,303870000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,20323000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Defined Pension Benefit,20320000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,3810000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,33840000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Held To Maturity Securities,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,33840000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,0.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Trading Securities,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,0.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Goodwill,0.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,242780000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-85910000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,328690000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,59280000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,18020000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,163800000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,87590000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,1645590000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,80702000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Hedging Assets Current,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Assets Held For Sale Current,0.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Deferred Assets,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,83000000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Inventory,206760000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,117880000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,10810000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,78070000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,208720000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-6000000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,214720000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,1147110000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,1036580000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,110530000.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,0.0
JAGSNPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,110530000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,65495000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,65495000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,1327290000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,1327590000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,821090000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,1327290000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,1327590000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,1327590000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,1327590000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,1327590000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,1177566000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Fixed Assets Revaluation Reserve,78392000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,693710000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,6000000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,130990000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,130990000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,314660000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,44940000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,12560000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,32380000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,12565000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,269720000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,230000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Deferred Taxes Liabilities,79613000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,4900000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,4901000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Payables,262790000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,74960000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,2330000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,185500000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,1642250000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,551440000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,29226000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Defined Pension Benefit,24190000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,290550000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Held To Maturity Securities,10179000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,201670000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,88880000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Trading Securities,
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,300000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,23453000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Goodwill,300000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,225730000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-355270000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,581000000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,223729000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,329610000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,163800000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,87590000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,1090810000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,-81000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Hedging Assets Current,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Assets Held For Sale Current,
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Deferred Assets,0.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,8940000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,163610000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Inventory,297420000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,144690000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,27020000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,125710000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,1370000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,155770000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-4770000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,160540000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,474010000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,248750000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,225260000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,27965000.0
JAGSNPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,225260000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Fixed Assets Revaluation Reserve,78392000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,585887000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,6000000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,180000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,0.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Deferred Taxes Liabilities,38215000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,67880000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,8470000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Payables,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,20775000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,26200000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,4500000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Defined Pension Benefit,0.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,50198000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,0.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Held To Maturity Securities,10179000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,10179000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Trading Securities,110627000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,300000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,23453000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Goodwill,300000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-343980000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,0.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,328990000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,160870000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,87590000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Hedging Assets Current,0.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Assets Held For Sale Current,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Deferred Assets,0.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,3114000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,143350000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,103129000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,124692000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,69424000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,15372000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-4348000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,130988000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,491826000.0
JAGSNPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,94489000.0
